CYCCP
Price:
$5.05
Market Cap:
$5.09M
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing therapeutic solutions for cancer and various other proliferative disorders. At the forefront of its pipeline are several investigational therapies: Fadraciclib, a cyclin-dependent kinase (CDK) inhibitor, is currently undergoing Phase 1/2 clinical evaluation. It's being assessed as a monotherapy for solid tumors and in combination with venetoclax for managing relapsed or refractory chronic lymphocytic leukemia. Another promising candidate is CYC140, a polo-like kinase inhibitor, also progressing through Phase 1/2 trials for advanced leukemias and various solid tumor types. The pipeline further fea...[Read more]
Industry
Biotechnology
IPO Date
2005-11-30
Stock Exchange
NASDAQ
Ticker
CYCCP
According to Cyclacel Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.30M. This represents a change of -21.43% compared to the average of 1.66M of the last 4 quarters.
The mean historical Enterprise Value of Cyclacel Pharmaceuticals, Inc. over the last ten years is -16220541.53. The current 1.30M Enterprise Value has changed -903.52% with respect to the historical average. Over the past ten years (40 quarters), CYCCP's Enterprise Value was at its highest in in the June 2025 quarter at 5.27M. The Enterprise Value was at its lowest in in the March 2021 quarter at -46769128.83.
Average
-16220541.53
Median
-17011351.22
Minimum
-36514076.42
Maximum
-269089.00
Discovering the peaks and valleys of Cyclacel Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 202.48%
Maximum Annual Enterprise Value = -269089.00
Minimum Annual Increase = -90.77%
Minimum Annual Enterprise Value = -36514076.42
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -269089.00 | -90.77% |
| 2024 | -2914783.74 | -12.20% |
| 2023 | -3319659.10 | -81.78% |
| 2022 | -18220181.48 | -50.10% |
| 2021 | -36514076.42 | 12.90% |
| 2020 | -32342925.82 | 202.48% |
| 2019 | -10692635.32 | -38.91% |
| 2018 | -17502988.80 | -26.79% |
| 2017 | -23909361.95 | 44.73% |
| 2016 | -16519713.63 | -19.18% |
The current Enterprise Value of Cyclacel Pharmaceuticals, Inc. (CYCCP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2167843.95
5-year avg
-12247557.95
10-year avg
-16220541.53
Cyclacel Pharmaceuticals, Inc.’s Enterprise Value is greater than Applied Molecular Transport Inc. (0), greater than ObsEva S.A. (-14017713.00), less than Scorpius Holdings, Inc. (5.60M), less than Gelesis Holdings, Inc. (17.55M), less than Korro Bio, Inc. (54.86M), less than Notable Labs, Ltd. (122.59M), greater than TuHURA Biosciences, Inc. (-7381410.00), less than Axcella Health Inc. (136.01M), greater than Millendo Therapeutics, Inc. (-2482600.00), less than null (17.93M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 0 | $11.01M | |
| -14017713.00 | $11.00M | |
| 5.60M | $12.39K | |
| 17.55M | $11.63M | |
| 54.86M | $105.28M | |
| 122.59M | $2.39M | |
| -7381410.00 | $136.60M | |
| 136.01M | $12.50M | |
| -2482600.00 | $11.15M | |
| 17.93M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclacel Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cyclacel Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cyclacel Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cyclacel Pharmaceuticals, Inc. (CYCCP)?
What is the 3-year average Enterprise Value for Cyclacel Pharmaceuticals, Inc. (CYCCP)?
What is the 5-year average Enterprise Value for Cyclacel Pharmaceuticals, Inc. (CYCCP)?
How does the current Enterprise Value for Cyclacel Pharmaceuticals, Inc. (CYCCP) compare to its historical average?